Aug 04 2015
By Joel Musee, Frist Global Health LeaderI was lucky to have travelled to Kijabe at an exciting time; there has been an increase in awareness in the medical community about the lack of access to safe anesthesia in low-middle income countries. The GE corporation has been prescient and magnanimous in their support of the efforts by anesthesiologists at Vanderbilt to create a sustainable program to educate Kenyan nurse anesthetists on how to provide a safe anesthetic.
Aug 01 2015
By Emily duBois, Frist Global Health LeaderThe travel time was the most painstaking part of the process to return to Rwanda, not because it took me over 24 hours but because I was just so ready to be back. They say third time’s a charm so I guess we shall see. The first time I arrived was in 2009, I was as a freshly graduated young adult with hopes of changing the world. The Peace Corps was instrumental in curbing my idealism and provided a better picture of what development and progress looks like.
By Sarah Boseley, The Guardian Health editor
July 31, 2015 | The Guardian
A vaccine against Ebola has been shown to be 100% successful in trials conducted during the outbreak in Guinea and is likely to bring the west African epidemic to an end, experts say.
The results of the trials involving 4,000 people are remarkable because of the unprecedented speed with which the development of the vaccine and the testing were carried out.
Scientists, doctors, donors and drug companies collaborated to race the vaccine through a process that usually takes more than a decade in just 12 months.
“Having seen the devastating effects of Ebola on communities and even whole countries with my own eyes, I am very encouraged by today’s news,” said Børge Brende, the foreign minister of Norway, which helped fund the trial.
“This new vaccine, if the results hold up, may be the silver bullet against Ebola, helping to bring the current outbreak to zero and to control future outbreaks of this kind. I would like to thank all partners who have contributed to achieve this sensational result, due to an extraordinary and rapid collaborative effort,” he said on Friday.
There have been a total of 27,748 cases of Ebola in Guinea, Liberia and Sierra Leone up to 26 July, with 11,279 reported deaths, although the outcome of many cases is unknown and the toll will be significantly higher. In the week ending 26 July, there were just four new cases in Guinea and three in Sierra Leone.
July 24, 2015 | Belmont University
When doctorate of nursing practice student Jennifer Quigley realized she would be the first Belmont recipient of the Frist Global Health Fellowship, she said she was eager to use her passion for global health to implement a plan for teaching health care providers in Cap-Haitien, Haiti a modern method of natural family planning. Her trip was born of a partnership between Belmont’s College of Health Sciences and Nursing and the organization Hope Through Healing Hands, which was founded by Former U.S. Senate Majority Leader Bill Frist, M.D.
Although the goal of the trip was to assist the Haitian people, Quigley was quick to say the trip was life-changing for her, as well. “I learned so much more from the Haitian people than they learned from me. I have never seen a more joyous people, full of life and love, and each was eager to show me love. Though they did not have much, I never went hungry, and I always had water. They joyfully give, even if they have so little to start with,” she said. “I also had the opportunity to deliver a baby, with only one other nurse, no drugs and not sterile equipment — only a clean room and the two of us. It was an experience I will hold with me for the rest of my life.”
By Harriet Alexander
July 24, 2015 | The Telegraph
The vaccine, named Mosquirix, was given the green light on Friday after more than 30 years of research, detailed in 230,000 pages of data. It now means that the vaccine will be examined by the World Health Organisation and, if approved, could be administered to children across Africa within the next few years.
"It's massively significant," said Allan Pamba, vice president for pharmaceuticals in East Africa for GlaxoSmithKline (GSK), which has spent more than $356 million (£230m) to date on finding a vaccine. GSK expects to invest a further $200 to $250 million until development is completed. In January 2001, GSK and PATH Malaria Vaccine Initiative, with grant monies from the Bill & Melinda Gates Foundation to PATH, entered into a public-private partnership to develop a vaccine. PATH has invested more than $200 million, much of it from the Gateses.
"Malaria has been incredibly difficult to crack. It's been tremendously frustrating. But we are all immensely proud to have reached this milestone."
By Angie Boehmer, Frist Global Health LeaderData is important. Because of data collection and monitoring, UNICEF can report that, “On average, one out of every 11 children born in sub-Saharan Africa dies before the age of 5.” In this example, data demonstrates the magnitude of the problem and serves as a catalyst for people to come together to develop strategies and implement programs to improve child health. Then, with continued data collection and monitoring, progress towards reducing child mortality can be measured.
Interview by Timothy C. Morgan
June 29, 2015 | Christianity Today
Melinda Gates describes herself as an “impatient optimist,” something that was nurtured in her while attending Ursuline Academy, the leading Catholic all-girls school in Dallas.
Since Melinda and husband Bill created the Gates Foundation in 2000, they have given away $33.5 billion of their massive wealth from Microsoft and from their close friend, billionaire Warren Buffett. The foundation started the same year as the United Nations Millennium Development Goals, the 15-year antipoverty campaign centered on 8 global objectives. The two programs share many priorities, such as fighting diseases, reducing extreme poverty, and improving maternal health. The foundation partners with a wide spectrum of organizations. Faith-based groups— including Catholic organizations, World Vision, Lutheran groups, and the Salvation Army—are key recipients of more than 125 foundation grants.
This January, Melinda and Bill Gates announced they were “doubling down” on their poverty-fighting efforts. “The lives of people in poor countries will improve faster in the next 15 years than at any other time in history,” they said. But along with the foundation’s big bets and big spending has come big controversy. In 2012, the couple helped launch Family Planning 2020, a global effort to make voluntary, artificial contraception available to 120 million poor women by 2020.
Jun 26 2015
June 26, 2015 | Partners In Health
Partners In Health is launching a new initiative in Rwanda—the University of Global Health Equity (UGHE). A different kind of university, UGHE will harness the best ideas in higher education and integrate cutting-edge technology platforms with immersion in complex health care delivery systems.
Owned and operated by PIH, UGHE is a private institution that will leverage expertise and resources from the government of Rwanda, Harvard Medical School, and key partners to create a forum for delivery-focused teaching, research, clinical care, and implementation. Classes will be taught by local and international experts including Harvard Medical School faculty. Students will learn from a broad network of global policymakers, leading research scientists, community health workers, and social entrepreneurs. UGHE’s academic programs aim to cultivate global health leaders with the vision to tackle consequential challenges and the pragmatic leadership skills to effect transformational change.
“UGHE will train the next generation of Rwandan and global leaders in health care delivery, making Rwanda an international hub for delivery science,” said UGHE Executive Director Dr. Peter Drobac. Drobac will teach an innovative course this September that explores key principles of global health.
PIH has focused on delivering high-quality health care and social services in some of the world’s poorest communities for nearly 30 years. For the past decade, PIH has worked in close partnership with the government of Rwanda, helping to strengthen a health care system that has achieved record improvements in health. This new university is an exciting next step for PIH in Rwanda.
UGHE is actively recruiting students to participate in the inaugural Master of Science in Global Health Delivery (MGHD) degree, which begins in September 2015. The MGHD will be the university’s flagship program, providing a one-of-a-kind learning experience rooted in the principles of global health delivery and One Health, and incorporating policy, management, finance, and leadership. Students with professional experience in health care management and administration, veterinary science, policy, and research will have opportunities to connect and collaborate with global health colleagues and peers throughout the program. Over the coming years, UGHE will add programs in undergraduate medicine, nursing, and dentistry, and graduate programs in veterinary medicine and health management.
Rwanda’s Honorable Minister of Health, Dr. Agnes Binagwaho, a Harvard Medical School senior lecturer and UGHE professor, is passionate about the university’s launch. She looks forward to teaching biological and social determinants of health.
“I have always dreamed that putting academic rigor into health sector management at all levels—local, national, regional, and beyond—would greatly improve the health of the population,” said Binagwaho. “This is exactly what UGHE will do for Rwanda and for the world. I am so excited to be part of this outstanding initiative.”
The two-year, part-time program is designed to complement students’ full-time jobs and scheduled so that students can remain employed. Beginning with a week in residence in Rwinkwavu, the course will meet one night per week in Kigali and one weekend a month in Rwinkwavu, while the first of two state-of-the-art permanent UGHE campuses is under development in Butaro.
Those who wish to apply can visit www.ughe.org.